Cao A - Search Results

Year	Number of Results
1965	2
1966	6
1967	8
1968	7
1969	9
1970	4
1971	10
1972	1
1973	5
1974	1
1975	5
1976	1
1977	3
1978	6
1979	8
1980	9
1981	20
1982	12
1983	13
1984	12
1985	6
1986	13
1987	11
1988	18
1989	12
1990	15
1991	17
1992	21
1993	17
1994	24
1995	8
1996	14
1997	14
1998	22
1999	14
2000	7
2001	8
2002	24
2003	15
2004	27
2005	29
2006	30
2007	33
2008	42
2009	39
2010	62
2011	51
2012	66
2013	64
2014	62
2015	68
2016	73
2017	82
2018	80
2019	96
2020	104
2021	107
2022	145
2023	146
2024	158
2025	132

1

Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies.

Zhang YB, Pan XF, Chen J, Cao A, Xia L, Zhang Y, Wang J, Li H, Liu G, Pan A. Zhang YB, et al. Among authors: cao a. J Epidemiol Community Health. 2021 Jan;75(1):92-99. doi: 10.1136/jech-2020-214050. Epub 2020 Sep 5. J Epidemiol Community Health. 2021. PMID: 32892156

2

PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.

Hennigs JK, Cao A, Li CG, Shi M, Mienert J, Miyagawa K, Körbelin J, Marciano DP, Chen PI, Roughley M, Elliott MV, Harper RL, Bill MA, Chappell J, Moonen JR, Diebold I, Wang L, Snyder MP, Rabinovitch M. Hennigs JK, et al. Among authors: cao a. Circ Res. 2021 Feb 5;128(3):401-418. doi: 10.1161/CIRCRESAHA.119.316339. Epub 2020 Dec 16. Circ Res. 2021. PMID: 33322916 Free PMC article.

3

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Cao A, Cartmel B, Li FY, Gottlieb LT, Harrigan M, Ligibel JA, Gogoi R, Schwartz PE, Esserman DA, Irwin ML, Ferrucci LM. Cao A, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2326463. doi: 10.1001/jamanetworkopen.2023.26463. JAMA Netw Open. 2023. PMID: 37526937 Free PMC article. Clinical Trial.

4

Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies.

Zhang Y, Pan XF, Chen J, Xia L, Cao A, Zhang Y, Wang J, Li H, Yang K, Guo K, He M, Pan A. Zhang Y, et al. Among authors: cao a. Diabetologia. 2020 Jan;63(1):21-33. doi: 10.1007/s00125-019-04985-9. Epub 2019 Sep 4. Diabetologia. 2020. PMID: 31482198

5

Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis.

Doke T, Huang S, Qiu C, Liu H, Guan Y, Hu H, Ma Z, Wu J, Miao Z, Sheng X, Zhou J, Cao A, Li J, Kaufman L, Hung A, Brown CD, Pestell R, Susztak K. Doke T, et al. Among authors: cao a. J Clin Invest. 2021 May 17;131(10):e141801. doi: 10.1172/JCI141801. J Clin Invest. 2021. PMID: 33998598 Free PMC article.

6

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

He M, Hao S, Ma L, Xiu B, Yang B, Wang Z, Xue J, Chi Y, Xiong M, Chen J, Huang X, Liu X, Wu S, Xiao Q, Huang Y, Shui R, Cao A, Li J, Di G, Yang W, Hu X, Liu G, Yu K, Jiang Y, Wang Z, Shao Z, Wu J. He M, et al. Among authors: cao a. EClinicalMedicine. 2024 Jun 28;74:102700. doi: 10.1016/j.eclinm.2024.102700. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39045544 Free PMC article.

7

Correction of age-associated defects in dendritic cells enables CD4⁺ T cells to eradicate tumors.

Zhivaki D, Kennedy SN, Park J, Boriello F, Devant P, Cao A, Bahleda KM, Murphy S, McCabe C, Evavold CL, Chapman KL, Zanoni I, Ashenberg O, Xavier RJ, Kagan JC. Zhivaki D, et al. Among authors: cao a. Cell. 2024 Jul 25;187(15):3888-3903.e18. doi: 10.1016/j.cell.2024.05.026. Epub 2024 Jun 12. Cell. 2024. PMID: 38870946 Free PMC article.

8

Bivalve Haemocyte Subpopulations: A Review.

de la Ballina NR, Maresca F, Cao A, Villalba A. de la Ballina NR, et al. Among authors: cao a. Front Immunol. 2022 Apr 8;13:826255. doi: 10.3389/fimmu.2022.826255. eCollection 2022. Front Immunol. 2022. PMID: 35464425 Free PMC article. Review.

9

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.

Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: cao ay. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.

10

Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.

Shen Q, Fang J, Guo H, Su X, Zhu B, Yao X, Wang Y, Cao A, Wang H, Wang L. Shen Q, et al. Among authors: cao a. Free Radic Biol Med. 2023 Jul;203:45-57. doi: 10.1016/j.freeradbiomed.2023.03.022. Epub 2023 Apr 6. Free Radic Biol Med. 2023. PMID: 37030337 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,924 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,924 results

Results by year